Application 077896
- Type
- ANDA
- Sponsor
- FOUGERA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CICLOPIROX | CICLOPIROX | GEL;TOPICAL | 0.77% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077896-001 | CICLOPIROX | CICLOPIROX | 0.77% | GEL / TOPICAL | AB | 2008-06-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077896-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077896-001 | CICLOPIROX | 0.77% | GEL / TOPICAL | AB | 2008-06-10 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077896-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ciclopirox | CICLOPIROX | Acella Pharmaceuticals, LLC | a08137a9-331f-4615-9752-e2cb52b3d8fc | 2026-07-10 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| Ciclopirox | CICLOPIROX | Bryant Ranch Prepack | d7e22682-1485-47e5-b6ae-94534bd3d889 | 2026-06-22 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| Ciclopirox | CICLOPIROX | Acella Pharmaceuticals, LLC | 2c67dd09-ab1f-4ccf-97b5-421356f64f22 | 2026-06-19 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| Ciclopirox | CICLOPIROX | Preferred Pharmaceuticals, Inc. | efcd78c0-2426-4fcc-a1c8-527e4e6f99d3 | 2026-03-27 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| CICLOPIROX | CICLOPIROX | Bryant Ranch Prepack | f3e0ea78-42c0-4430-b299-fffee9e09c16 | 2026-03-18 | Warnings, Adverse reactions | CICLOPIROX CICLOPIROX |
| CICLOPIROX | CICLOPIROX | Encube Ethicals, Inc. | cb456f2e-6645-4cc4-8e71-299c47ccb6b7 | 2026-01-30 | Warnings, Adverse reactions | CICLOPIROX CICLOPIROX |
| ciclopirox | CICLOPIROX | Glenmark Pharmaceuticals Inc., USA | 3c22416e-4293-4ba5-a983-137cbc6022db | 2026-01-23 | Warnings, Adverse reactions | ciclopirox CICLOPIROX |
| CICLOPIROX | CICLOPIROX | Preferred Pharmaceuticals Inc. | eb7b7163-2ee7-447a-b585-7a240070f84b | 2026-01-19 | Warnings, Adverse reactions | CICLOPIROX CICLOPIROX |
| Ciclopirox | CICLOPIROX | A-S Medication Solutions | b281493f-ce8c-42f8-95c7-2eb1c9712157 | 2025-11-12 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| CICLOPIROX | CICLOPIROX | Bryant Ranch Prepack | 1548af93-0dc1-4606-865f-6201b2bb7de1 | 2025-10-22 | Warnings, Adverse reactions | CICLOPIROX CICLOPIROX |
| Ciclopirox | CICLOPIROX | Chartwell RX, LLC | 8ce98020-5615-4332-bf57-72777e2ce038 | 2025-10-21 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| CICLOPIROX | CICLOPIROX | Encube Ethicals, Inc. | 79084b47-7481-4926-9837-e08f633b1ddf | 2025-10-13 | Warnings, Adverse reactions | CICLOPIROX CICLOPIROX |
| CICLOPIROX | CICLOPIROX | Bryant Ranch Prepack | 51993bbb-f145-4662-8138-4db774cc0513 | 2025-09-16 | Warnings, Adverse reactions | CICLOPIROX CICLOPIROX |
| ciclopirox | CICLOPIROX | Bryant Ranch Prepack | 810bfb01-a69d-4b00-ac2d-b92e7ddad9f9 | 2025-08-08 | Warnings, Adverse reactions | ciclopirox CICLOPIROX |
| Ciclopirox | CICLOPIROX | Sun Pharmaceutical Industries, Inc. | b44b190b-8e2a-4937-a6c5-92f37911e7f8 | 2025-07-07 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| CICLOPIROX | CICLOPIROX | Padagis US LLC | b6a02568-867b-4c7b-890f-5d28bf0b363d | 2024-11-01 | Warnings, Adverse reactions | CICLOPIROX CICLOPIROX |
| Ciclopirox | CICLOPIROX | Bryant Ranch Prepack | aaa27021-68a6-486c-9095-56de1140ca2d | 2024-03-21 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| Ciclopirox | CICLOPIROX | Actavis Pharma, Inc. | eef13684-751f-47e1-b75e-3401a0e6e20f | 2023-10-30 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| Ciclopirox | CICLOPIROX | Bryant Ranch Prepack | 9c7d1fd9-71dd-4bbb-aed2-7db5cffa8b5a | 2023-07-17 | Warnings, Adverse reactions | Ciclopirox CICLOPIROX |
| CICLOPIROX | CICLOPIROX | Bryant Ranch Prepack | 9861c88d-528f-4e30-8c1e-56ac3afec76c | 2023-07-17 | Warnings, Adverse reactions | CICLOPIROX CICLOPIROX |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0168-0407 | Ciclopirox | Ciclopirox | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA | Current |